Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy

Mengxia Chen, Yao Fu, Shan Peng, Shiming Zang, Shuyue Ai, Junlong Zhuang, Feng Wang, Xuefeng Qiu and Hongqian Guo
Journal of Nuclear Medicine October 2023, 64 (10) 1550-1555; DOI: https://doi.org/10.2967/jnumed.122.265368
Mengxia Chen
1Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China;
2Institute of Urology, Nanjing University, Nanjing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yao Fu
3Department of Pathology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shan Peng
3Department of Pathology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiming Zang
4Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuyue Ai
4Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junlong Zhuang
1Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China;
2Institute of Urology, Nanjing University, Nanjing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Wang
4Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuefeng Qiu
1Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China;
2Institute of Urology, Nanjing University, Nanjing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongqian Guo
1Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China;
2Institute of Urology, Nanjing University, Nanjing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (10)
Journal of Nuclear Medicine
Vol. 64, Issue 10
October 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy
Mengxia Chen, Yao Fu, Shan Peng, Shiming Zang, Shuyue Ai, Junlong Zhuang, Feng Wang, Xuefeng Qiu, Hongqian Guo
Journal of Nuclear Medicine Oct 2023, 64 (10) 1550-1555; DOI: 10.2967/jnumed.122.265368

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy
Mengxia Chen, Yao Fu, Shan Peng, Shiming Zang, Shuyue Ai, Junlong Zhuang, Feng Wang, Xuefeng Qiu, Hongqian Guo
Journal of Nuclear Medicine Oct 2023, 64 (10) 1550-1555; DOI: 10.2967/jnumed.122.265368
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • [68Ga]PSMA PET/CT
  • prostate cancer
  • neoadjuvant therapy
  • biochemical progression
  • prediction
SNMMI

© 2025 SNMMI

Powered by HighWire